血管内取栓与急性卒中伴大缺血核心患者功能结局的关联
这项多中心回顾性登记研究分析了299例CT灌注核心体积≥70 mL的急性卒中患者,其中269例数据完整。取栓组获得良好结局(3个月mRS 0-3)的比例为30%,高于非取栓组的13.9%(aOR 2.1,95%CI 1-4.2,p=0.038)。获益主要见于核心体积70-100 mL亚组(54.3% vs 21%,aOR 2.5,95%CI 1-6.2,p=0.005),而≥100 mL亚组两组良好结局比例均很低(8.1% vs 8.7%,p=0.908)。
要点
- 核心体积70-100 mL者,取栓组良好结局54.3% vs 非取栓组21%(aOR 2.5,95%CI 1-6.2,p=0.005)。
- 核心体积≥100 mL者,取栓组良好结局8.1% vs 非取栓组8.7%(p=0.908),两组均很低。
- 该研究提供III级证据,取栓与70-100 mL核心卒中3个月较好运动结局相关。
核心结论
- 在基线CT灌注缺血核心体积70-100 mL的患者中,血管内取栓与3个月良好结局正相关;在核心体积≥100 mL的患者中未观察到这种关联。
- 作者认为需要随机对照数据来确认这些发现。
研究设计与样本
- 多中心(澳大利亚、中国、加拿大)登记研究的回顾性分析,纳入2012-2020年卒中发作24小时内完成CT灌注且基线缺血核心体积≥70 mL的患者。
- 登记共3283例,299例核心体积≥70 mL,269例数据完整(核心体积70-100 mL者135例,≥100 mL者134例);121例(45%)接受了血管内取栓。
主要发现
- 取栓组患者较年轻(中位69岁 vs 75岁,p=0.011),病前mRS较低,中位核心体积较小(92 [79-116.5] mL vs 105.5 [85.75-138] mL,p=0.004)。
- 取栓组达到良好结局的比例为30%,非取栓组为13.9%(校正OR 2.1,95%CI 1-4.2,p=0.038)。
- 核心体积70-100 mL亚组中,取栓组(71/135,52.6%接受取栓)良好结局54.3% vs 非取栓组21%(aOR 2.5,95%CI 1-6.2,p=0.005)。
- 核心体积≥100 mL亚组中,134例中50例(37.3%)接受取栓,两组良好结局比例分别为8.1% vs 8.7%(p=0.908)。
局限性
- 原文为回顾性分析。
- 作者指出需要随机对照数据来确认这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Endovascular thrombectomy (EVT) is effective for patients with large vessel occlusion (LVO) stroke with smaller volumes of CT perfusion (CTP)-defined ischemic core. However, the benefit of EVT is unclear in those with a core volume >70 mL. We aimed to compare outcomes of EVT and non-EVT patients with an ischemic core volume ≥70 mL, hypothesizing that there would be a benefit from EVT for fair outcome (3-month modified Rankin scale [mRS] 0-3) after stroke. METHODS: A retrospective analysis of patients enrolled into a multicenter (Australia, China, and Canada) registry (2012-2020) who underwent CTP within 24 hours of stroke onset and had a baseline ischemic core volume ≥70 mL was performed. The primary outcome was the estimation of the association of EVT in patients with core volume ≥70 mL and within 70-100 and ≥100 mL subgroups with fair outcome. RESULTS: Of the 3,283 patients in the registry, 299 had CTP core volume ≥70 mL and 269 complete data (135 had core volume between 70 and 100 mL and 134 had core volume ≥100 mL). EVT was performed in 121 (45%) patients. EVT-treated patients were younger (median 69 vs 75 years; p = 0.011), had lower prestroke mRS, and smaller median core volumes (92 [79-116.5] mL vs 105.5 [85.75-138] mL, p = 0.004). EVT-treated patients had higher odds of achieving fair outcome in adjusted analysis (30% vs 13.9% in the non-EVT group; adjusted odds ratio [aOR] 2.1, 95% CI 1-4.2, p = 0.038). The benefit was seen predominantly in those with 70-100 mL core volume (71/135 [52.6%] EVT-treated), with 54.3% in the EVT-treated vs 21% in the non-EVT group achieving a fair outcome (aOR 2.5, 95% CI 1-6.2, p = 0.005). Of those with a core volume ≥100 mL, 50 of the 134 (37.3%) underwent EVT. Proportions of fair outcome were very low in both groups (8.1% vs 8.7%; p = 0.908). DISCUSSION: We found a positive association of EVT with the 3-month outcome after stroke in patients with a baseline CTP ischemic core volume 70-100 mL but not in those with core volume ≥100 mL. Randomized data to confirm these findings are required. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that EVT is associated with better motor outcomes 3 months after CTP-defined ischemic stroke with a core volume of 70-100 mL.
引用
- Garcia-Esperon C, Bivard A, Johns H, et al. Association of Endovascular Thrombectomy With Functional Outcome in Patients With Acute Stroke With a Large Ischemic Core. Neurology. 2022. PMID: 35803723. doi:10.1212/WNL.0000000000200908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。